文献速递细菌感染、耐药与抗菌药物医院感染防控

血流分离株耐药率能否代表其他感染?BSAC耐药监测项目分析

Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该研究比较了BSAC耐药监测项目中血流感染(BSI)与下呼吸道感染(LRTI)分离株的耐药率。结果显示,LRTI分离株的耐药率普遍高于BSI,尤其对铜绿假单胞菌、肺炎链球菌和金黄色葡萄球菌,提示基于血流分离株的耐药估计可能低估呼吸道感染的耐药问题。

要点

  • 下呼吸道分离株耐药率普遍高于血流分离株。
  • 铜绿假单胞菌、肺炎链球菌和金黄色葡萄球菌差异最显著。
  • 肠杆菌目差异较小,但大肠埃希菌和肺炎克雷伯菌部分药物耐药率更高。

核心结论

  • 基于血流分离株的耐药率估计会低估呼吸道分离株的耐药程度,尤其对铜绿假单胞菌、肺炎链球菌和金黄色葡萄球菌。

研究设计与样本

  • 下呼吸道分离株按发病场所选择:肺炎链球菌为社区,金黄色葡萄球菌、铜绿假单胞菌和肠杆菌目为医院。
  • 采用琼脂稀释法中央测定MIC,统计模型调整ICU位置和收集中心的潜在聚集性。

主要发现

  • 调整ICU患者比例较高后,下呼吸道分离株的耐药率仍更普遍。
  • 下呼吸道铜绿假单胞菌和肺炎链球菌对多数抗生素的耐药率高于血流分离株,下呼吸道中MRSA比例更高。
  • 肺炎链球菌的差异反映了下呼吸道与血流分离株的血清型分布不同。
  • 肠杆菌目的下呼吸道与耐药关联较弱,但下呼吸道大肠埃希菌对β-内酰胺类(尤其青霉素/β-内酰胺酶抑制剂组合)更常耐药,下呼吸道肺炎克雷伯菌对哌拉西林/他唑巴坦更常耐药。
  • 阴沟肠杆菌中下呼吸道、AmpC酶产生与头孢菌素耐药之间仅呈弱关联。

临床怎么用

  • 临床经验性用药时应考虑感染部位,不能仅凭血流分离株耐药数据推断呼吸道病原体的耐药情况。

局限性

  • 下呼吸道分离株按发病场所选择(社区或医院),与血流分离株的选择方式不同,可能影响比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bacteraemia data are often used as a general measure of resistance prevalence but may poorly represent other infection types. We compared resistance prevalence between bloodstream infection (BSI) and lower respiratory tract infection (LRTI) isolates collected by the BSAC Resistance Surveillance Programme. METHODS: BSI isolates (n = 8912) were collected during 2014-18 inclusive and LRTI isolates (n = 6280) between October 2013 to September 2018 from participating laboratories in the UK and Ireland, to a fixed annual quota per species group. LRTI isolates, but not BSI, were selected by onset: community for Streptococcus pneumoniae; hospital for Staphylococcus aureus, Pseudomonas aeruginosa and Enterobacterales. MICs were determined centrally by agar dilution; statistical modelling adjusted for ICU location and possible clustering by collection centre. RESULTS: Resistance was more prevalent among the LRTI isolates, even after adjusting for a larger proportion of ICU patients. LRTI P. aeruginosa and S. pneumoniae were more often resistant than BSI isolates for most antibiotics, and the proportion of MRSA was higher in LRTI. For S. pneumoniae, the observation reflected different serotype distributions in LRTI and BSI. Relationships between LRTI and resistance were less marked for Enterobacterales, but LRTI E. coli were more often resistant to β-lactams, particularly penicillin/β-lactamase inhibitor combinations, and LRTI K. pneumoniae to piperacillin/tazobactam. For E. cloacae there was a weak association between LRTI, production of AmpC enzymes and cephalosporin resistance. CONCLUSIONS: Estimates of resistance prevalence based upon bloodstream isolates underestimate the extent of the problem in respiratory isolates, particularly for P. aeruginosa, S. pneumoniae, S. aureus and, less so, for Enterobacterales.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Horner C, Mushtaq S, Allen M, et al. Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme. J Antimicrob Chemother. 2021. PMID: 33822968. doi:10.1093/jac/dkab096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。